Schroder Investment Management Group
MBX

Schroder Investment Management Group’s MBX Biosciences MBX Stock Holding History

Schroder Investment Management Group’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57,322
Closed -$1.54M – 1260
2026
Q1 		$1.54M Sell
57,322
-16,414
-22% -$558K ﹤0.01% 973
2025
Q4 		$2.28M Sell
73,736
-10,030
-12% -$243K ﹤0.01% 870
2025
Q3 		$1.5M Buy
+83,766
New +$1.12M ﹤0.01% 975

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Schroder Investment Management Group's MBX Position: Q2 2026 in Review

Schroder Investment Management Group sold out of MBX Biosciences (MBX) in Q2 2026, closing a stake of 57,322 shares — an estimated $1.54M sold.

Schroder Investment Management Group first reported a position in MBX in Q3 2025 and held it in 3 quarters. The position peaked at $2.28M in Q4 2025. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Schroder Investment Management Group reported no remaining MBX Biosciences position as of Q2 2026 after selling out during the quarter.
  • Schroder Investment Management Group sold 57,322 MBX Biosciences shares in Q2 2026, an estimated $1.54M.
  • Schroder Investment Management Group first reported a position in MBX Biosciences in Q3 2025 and held it in 3 quarters.
  • Schroder Investment Management Group's MBX Biosciences position peaked at $2.28M in Q4 2025.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.